Shanghai UniXell Biotechnology Co., Ltd
Shanghai UniXell Biotechnology Co., Ltd
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-29 | NCT07733349 | |
| A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Not yet recruiting | Phase 1 | 2026-07-27 | NCT07572812 | |
| An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Active, not recruiting | Phase 1 | 2026-06-11 | NCT06778265 | |
| Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) | Drug Resistant Epilepsy, brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Early phase 1 | 2026-04-22 | NCT07244328 |